144 related articles for article (PubMed ID: 16104909)
1. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
Leuenroth S; Riethdorf S; Erbersdobler A; Riethdorf L; Löning T; Huland H; Friedrich MG
BJU Int; 2005 Sep; 96(4):553-7. PubMed ID: 16104909
[TBL] [Abstract][Full Text] [Related]
2. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
3. Telomerase expression in sebaceous carcinoma of the eyelid.
Li B; Li ND; Xu XL; Zheng BH; Sun XL; Li LQ; Chen CX
Chin Med J (Engl); 2004 Mar; 117(3):445-8. PubMed ID: 15043789
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A
Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771
[TBL] [Abstract][Full Text] [Related]
5. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
7. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
8. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
9. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization.
Soder AI; Going JJ; Kaye SB; Keith WN
Oncogene; 1998 Feb; 16(8):979-83. PubMed ID: 9519871
[TBL] [Abstract][Full Text] [Related]
10. Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Hiroi S; Kumaki F; Torikata C; Aurues T; Ikeda T
Cancer; 1999 Nov; 86(10):2109-16. PubMed ID: 10570439
[TBL] [Abstract][Full Text] [Related]
11. Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder.
Kong QY; Liu J; Chen XY; Wang XW; Sun Y; Li H
Oncol Rep; 2003; 10(1):51-5. PubMed ID: 12469144
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
13. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
15. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
[TBL] [Abstract][Full Text] [Related]
16. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
17. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.
Yashima K; Litzky LA; Kaiser L; Rogers T; Lam S; Wistuba II; Milchgrub S; Srivastava S; Piatyszek MA; Shay JW; Gazdar AF
Cancer Res; 1997 Jun; 57(12):2373-7. PubMed ID: 9192812
[TBL] [Abstract][Full Text] [Related]
18. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer.
Soder AI; Hoare SF; Muir S; Going JJ; Parkinson EK; Keith WN
Oncogene; 1997 Mar; 14(9):1013-21. PubMed ID: 9070649
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
20. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
Müller M; Krause H; Heicappell R; Tischendorf J; Shay JW; Miller K
Clin Cancer Res; 1998 Aug; 4(8):1949-54. PubMed ID: 9717824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
